“Orthopaedic disorders are typically associated with old age and Singapore’s well-insured ageing population is supporting the development of this burgeoning industry. AHS is well-positioned to tap the surge in demand for orthopaedic services and serves as a proxy to ride on the industry’s growth story,” he explains.
SINGAPORE (July 11): UOB Kay Hian is starting Asian Healthcare Specialists (AHS) at “buy” with a target price of 33 cents as it views the stock as a proxy to increased medical spending from Singapore’s ageing population and rising participation in sports.
In an initiation report on Wednesday, analyst Yeo Hai Wei says he sees FY19 as the start of a multi-year growth story for AHS as the group scales up to capture a bigger share of the market.
